-
1
-
-
12344282783
-
Global burden of hypertension: Analysis of worldwide data
-
DOI 10.1016/S0140-6736(05)17741-1, PII S0140673605177411
-
Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: Analysis of worldwide data. Lancet. 2005 ; 365: 217-223 (Pubitemid 40138015)
-
(2005)
Lancet
, vol.365
, Issue.9455
, pp. 217-223
-
-
Kearney, P.M.1
Whelton, M.2
Reynolds, K.3
Muntner, P.4
Whelton, P.K.5
He, J.6
-
2
-
-
34250350040
-
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
-
DOI 10.1097/HJH.0b013e3281fc975a, PII 0000487220070600000001
-
Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007 ; 25: 1105-1187 (Pubitemid 46924065)
-
(2007)
Journal of Hypertension
, vol.25
, Issue.6
, pp. 1105-1187
-
-
Mancia, G.1
De Backer, G.2
Dominiczak, A.3
Cifkova, R.4
Fagard, R.5
Germano, G.6
Grassi, G.7
Heagerty, A.M.8
Kjeldsen, S.E.9
Laurent, S.10
Narkiewicz, K.11
Ruilope, L.12
Rynkiewicz, A.13
Schmieder, R.E.14
Boudier, H.A.J.S.15
Zanchetti, A.16
-
3
-
-
0030970060
-
Estimation of Central aortic pressure waveform by mathematical transformation of radial tonometry pressure: Validation of generalized transfer function
-
Chen CH, Nevo E, Fetics B, et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation. 1997 ; 95: 1827-1836 (Pubitemid 27164400)
-
(1997)
Circulation
, vol.95
, Issue.7
, pp. 1827-1836
-
-
Chen, C.-H.1
Nevo, E.2
Fetics, B.3
Pak, P.H.4
Yin, F.C.P.5
Maughan, W.L.6
Kass, D.A.7
-
4
-
-
69549133604
-
Should proteinuria reduction be the criterion for antihypertensive drug selection for patients with kidney disease?
-
Kalaitzidis RG, Bakris GL. Should proteinuria reduction be the criterion for antihypertensive drug selection for patients with kidney disease?. Curr Opin Nephrol Hypertens. 2009 ; 18: 386-391
-
(2009)
Curr Opin Nephrol Hypertens
, vol.18
, pp. 386-391
-
-
Kalaitzidis, R.G.1
Bakris, G.L.2
-
5
-
-
34447521458
-
Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: A randomised, double-blind trial
-
DOI 10.1016/S0140-6736(07)61124-6, PII S0140673607611246
-
Oparil S, Yarows SA, Patel S, et al. Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: A randomised, double-blind trial. Lancet. 2007 ; 370: 221-229 (Pubitemid 47069535)
-
(2007)
Lancet
, vol.370
, Issue.9583
, pp. 221-229
-
-
Oparil, S.1
Yarows, S.A.2
Patel, S.3
Fang, H.4
Zhang, J.5
Satlin, A.6
-
6
-
-
33845785350
-
Aliskiren, an Orally Effective Renin Inhibitor, Provides Antihypertensive Efficacy Alone and in Combination With Valsartan
-
DOI 10.1016/j.amjhyper.2006.06.003, PII S0895706106003669
-
Pool JL, Schmieder RE, Azizi M, et al. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan. Am J Hypertens. 2007 ; 20: 11-20 (Pubitemid 46014059)
-
(2007)
American Journal of Hypertension
, vol.20
, Issue.1
, pp. 11-20
-
-
Pool, J.L.1
Schmieder, R.E.2
Azizi, M.3
Aldigier, J.-C.4
Januszewicz, A.5
Zidek, W.6
Chiang, Y.7
Satlin, A.8
-
7
-
-
33644853054
-
Arterial stiffness and risk of coronary heart disease and stroke: The Rotterdam Study
-
Mattace-Raso FU, van der Cammen TJ, Hofman A, et al. Arterial stiffness and risk of coronary heart disease and stroke: The Rotterdam Study. Circulation. 2006 ; 113: 657-663
-
(2006)
Circulation
, vol.113
, pp. 657-663
-
-
Mattace-Raso, F.U.1
Van Der Cammen, T.J.2
Hofman, A.3
-
8
-
-
33644863316
-
Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population
-
Willum-Hansen T, Staessen JA, Torp-Pedersen C, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006 ; 113: 664-670
-
(2006)
Circulation
, vol.113
, pp. 664-670
-
-
Willum-Hansen, T.1
Staessen, J.A.2
Torp-Pedersen, C.3
-
9
-
-
33750318148
-
Expert consensus document on arterial stiffness: Methodological issues and clinical applications
-
DOI 10.1093/eurheartj/ehl254
-
Laurent S, Cockcroft J, Van BL, et al. Expert consensus document on arterial stiffness: Methodological issues and clinical applications. Eur Heart J. 2006 ; 27: 2588-2605 (Pubitemid 44627304)
-
(2006)
European Heart Journal
, vol.27
, Issue.21
, pp. 2588-2605
-
-
Laurent, S.1
Cockcroft, J.2
Van Bortel, L.3
Boutouyrie, P.4
Giannattasio, C.5
Hayoz, D.6
Pannier, B.7
Vlachopoulos, C.8
Wilkinson, I.9
Struijker-Boudier, H.10
-
10
-
-
0036150671
-
Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: A longitudinal study
-
DOI 10.1161/hy0102.099031
-
Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: A longitudinal study. Hypertension. 2002 ; 39: 10-15 (Pubitemid 34098081)
-
(2002)
Hypertension
, vol.39
, Issue.1
, pp. 10-15
-
-
Boutouyrie, P.1
Tropeano, A.I.2
Asmar, R.3
Gautier, I.4
Benetos, A.5
Lacolley, P.6
Laurent, S.7
-
11
-
-
0035714567
-
Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients
-
Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001 ; 37: 1236-1241 (Pubitemid 34163575)
-
(2001)
Hypertension
, vol.37
, Issue.5
, pp. 1236-1241
-
-
Laurent, S.1
Boutouyrie, P.2
Asmar, R.3
Gautier, I.4
Laloux, B.5
Guize, L.6
Ducimetiere, P.7
Benetos, A.8
-
12
-
-
0012666855
-
Aortic stiffness is an independent predictor of fatal stroke in essential hypertension
-
DOI 10.1161/01.STR.0000065428.03209.64
-
Laurent S, Katsahian S, Fassot C, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003 ; 34: 1203-1206 (Pubitemid 36547514)
-
(2003)
Stroke
, vol.34
, Issue.5
, pp. 1203-1206
-
-
Laurent, S.1
Katsahian, S.2
Fassot, C.3
Tropeano, A.-I.4
Gautier, I.5
Laloux, B.6
Boutouyrie, P.7
-
13
-
-
0037109215
-
Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: An integrated index of vascular function?
-
DOI 10.1161/01.CIR.0000033824.02722.F7
-
Cruickshank K, Riste L, Anderson SG, et al. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: An integrated index of vascular function?. Circulation. 2002 ; 106: 2085-2090 (Pubitemid 35192814)
-
(2002)
Circulation
, vol.106
, Issue.16
, pp. 2085-2090
-
-
Cruickshank, K.1
Riste, L.2
Anderson, S.G.3
Wright, J.S.4
Dunn, G.5
Gosling, R.G.6
-
14
-
-
75149139972
-
Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: A pilot study
-
Cherney DZ, Lai V, Scholey JW, et al. Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: A pilot study. Diabetes Care. 2010 ; 33: 361-365
-
(2010)
Diabetes Care
, vol.33
, pp. 361-365
-
-
Cherney, D.Z.1
Lai, V.2
Scholey, J.W.3
-
15
-
-
33644851061
-
Arterial stiffness, vascular disease, and risk of cardiovascular events
-
Cohn JN. Arterial stiffness, vascular disease, and risk of cardiovascular events. Circulation. 2006 ; 113: 601-603
-
(2006)
Circulation
, vol.113
, pp. 601-603
-
-
Cohn, J.N.1
-
16
-
-
0035569613
-
Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men
-
Kelly RP, Millasseau SC, Ritter JM, et al. Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men. Hypertension. 2001 ; 37: 1429-1433 (Pubitemid 34225387)
-
(2001)
Hypertension
, vol.37
, Issue.6
, pp. 1429-1433
-
-
Kelly, R.P.1
Millasseau, S.C.2
Ritter, J.M.3
Chowienczyk, P.J.4
-
17
-
-
0035572004
-
Arterial wave reflections and survival in end-stage renal failure
-
London GM, Blacher J, Pannier B, et al. Arterial wave reflections and survival in end-stage renal failure. Hypertension. 2001 ; 38: 434-438 (Pubitemid 34225679)
-
(2001)
Hypertension
, vol.38
, Issue.3
, pp. 434-438
-
-
London, G.M.1
Blacher, J.2
Pannier, B.3
Guerin, A.P.4
Marchais, S.J.5
Safar, M.E.6
-
18
-
-
33645518432
-
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) study
-
Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006 ; 113: 1213-1225
-
(2006)
Circulation
, vol.113
, pp. 1213-1225
-
-
Williams, B.1
Lacy, P.S.2
Thom, S.M.3
-
19
-
-
84863588651
-
Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients
-
2012
-
Virdis A, Ghiadoni L, Qasem AA, et al. Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients. Eur Heart J. 2012 2012 ; 33: 1530-1538
-
(2012)
Eur Heart J
, vol.33
, pp. 1530-1538
-
-
Virdis, A.1
Ghiadoni, L.2
Qasem, A.A.3
-
20
-
-
7944233130
-
Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients
-
DOI 10.1016/j.amjhyper.2004.06.028, PII S0895706104009343
-
Munakata M, Nagasaki A, Nunokawa T, et al. Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients. Am J Hypertens. 2004 ; 17 (Pt 1). 1050-1055 (Pubitemid 39469329)
-
(2004)
American Journal of Hypertension
, vol.17
, Issue.11
, pp. 1050-1055
-
-
Munakata, M.1
Nagasaki, A.2
Nunokawa, T.3
Sakuma, T.4
Kato, H.5
Yoshinaga, K.6
Toyota, T.7
-
21
-
-
45849123477
-
Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering
-
Karalliedde J, Smith A, DeAngelis L, et al. Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering. Hypertension. 2008 ; 51: 1617-1623
-
(2008)
Hypertension
, vol.51
, pp. 1617-1623
-
-
Karalliedde, J.1
Smith, A.2
Deangelis, L.3
-
22
-
-
0028345245
-
Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment
-
Rossing P, Hommel E, Smidt UM, et al. Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. Diabetologia. 1994 ; 37: 511-516 (Pubitemid 24133655)
-
(1994)
Diabetologia
, vol.37
, Issue.5
, pp. 511-516
-
-
Rossing, P.1
Hommel, E.2
Smidt, U.M.3
Parving, H.-H.4
-
23
-
-
0037994715
-
Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease
-
Apperloo AJ, de Zeeuw D, de Jong PE. Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease. Kidney Int Suppl. 1994 ; 45: S174 - S178
-
(1994)
Kidney Int Suppl
, vol.45
-
-
Apperloo, A.J.1
De Zeeuw, D.2
De Jong, P.E.3
-
24
-
-
34248178511
-
Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: Post hoc analysis from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) trial
-
DOI 10.1681/ASN.2006050445
-
Eijkelkamp WB, Zhang Z, Remuzzi G, et al. Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: Post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. J Am Soc Nephrol. 2007 ; 18: 1540-1546 (Pubitemid 46717521)
-
(2007)
Journal of the American Society of Nephrology
, vol.18
, Issue.5
, pp. 1540-1546
-
-
Eijkelkamp, W.B.A.1
Zhang, Z.2
Remuzzi, G.3
Parving, H.-H.4
Cooper, M.E.5
Keane, W.F.6
Shahinfar, S.7
Gleim, G.W.8
Weir, M.R.9
Brenner, B.M.10
De Zeeuw, D.11
-
25
-
-
0029807227
-
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: A comparative study of the efficacy and safety against amlodipine
-
DOI 10.1016/S0009-9236(96)90061-2
-
Corea L, Cardoni O, Fogari R, et al. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: A comparative study of the efficacy and safety against amlodipine. Clin Pharmacol Ther. 1996 ; 60: 341-346 (Pubitemid 26354455)
-
(1996)
Clinical Pharmacology and Therapeutics
, vol.60
, Issue.3
, pp. 341-346
-
-
Corea, L.1
Cardoni, O.2
Fogari, R.3
Innocenti, P.4
Porcellati, C.5
Provvidenza, M.6
Meilenbrock, S.7
Sullivan, J.8
Bodin, F.9
-
26
-
-
0029969837
-
The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension
-
DOI 10.1016/S0149-2918(96)80040-3
-
Oparil S, Dyke S, Harris F, et al. The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension. Clin Ther. 1996 ; 18: 797-810 (Pubitemid 26397279)
-
(1996)
Clinical Therapeutics
, vol.18
, Issue.5
, pp. 797-810
-
-
Oparil, S.1
Dyke, S.2
Harris, F.3
Kief, J.4
James, D.5
Hester, A.6
Fitzsimmons, S.7
-
27
-
-
38049139424
-
Meta-analysis: Effect of monotherapy and combination therapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease
-
Kunz R, Friedrich C, Wolbers M, et al. Meta-analysis: Effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease. Ann Intern Med. 2008 ; 148: 30-48 (Pubitemid 351688350)
-
(2008)
Annals of Internal Medicine
, vol.148
, Issue.1
, pp. 30-48
-
-
Kunz, R.1
Friedrich, C.2
Wolbers, M.3
Mann, J.F.E.4
-
28
-
-
0347479295
-
Blood Pressure Lowering in Essential Hypertension with an Oral Renin Inhibitor, Aliskiren
-
DOI 10.1161/01.HYP.0000101688.17370.87
-
Stanton A, Jensen C, Nussberger J, et al. Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren. Hypertension. 2003 ; 42: 1137-1143 (Pubitemid 37549068)
-
(2003)
Hypertension
, vol.42
, Issue.6
, pp. 1137-1143
-
-
Stanton, A.1
Jensen, C.2
Nussberger, J.3
Obrien, E.4
-
29
-
-
46449118638
-
Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats
-
Feldman DL, Jin L, Xuan H, et al. Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats. Hypertension. 2008 ; 52: 130-136
-
(2008)
Hypertension
, vol.52
, pp. 130-136
-
-
Feldman, D.L.1
Jin, L.2
Xuan, H.3
-
30
-
-
25444454353
-
Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats
-
DOI 10.1161/01.HYP.0000179573.91016.3f
-
Pilz B, Shagdarsuren E, Wellner M, et al. Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats. Hypertension. 2005 ; 46: 569-576 (Pubitemid 41376839)
-
(2005)
Hypertension
, vol.46
, Issue.3
, pp. 569-576
-
-
Pilz, B.1
Shagdarsuren, E.2
Wellner, M.3
Fiebeler, A.4
Dechend, R.5
Gratze, P.6
Meiners, S.7
Feldman, D.L.8
Webb, R.L.9
Garrelds, I.M.10
Danser, A.H.J.11
Luft, F.C.12
Muller, D.N.13
-
31
-
-
44849114597
-
Aliskiren combined with losartan in type 2 diabetes and nephropathy
-
DOI 10.1056/NEJMoa0708379
-
Parving HH, Persson F, Lewis JB, et al. Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med. 2008 ; 358: 2433-2446 (Pubitemid 351793017)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.23
, pp. 2433-2446
-
-
Parving, H.-H.1
Persson, F.2
Lewis, J.B.3
Lewis, E.J.4
Hollenberg, N.K.5
-
32
-
-
70349690296
-
Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria
-
Persson F, Rossing P, Reinhard H, et al. Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria. Diabetes Care. 2009 ; 32: 1873-1879
-
(2009)
Diabetes Care
, vol.32
, pp. 1873-1879
-
-
Persson, F.1
Rossing, P.2
Reinhard, H.3
|